OSTEOPOROZA DE POSTMENOPAUZA

CONF. DR. DANIEL GRIGORIE

INSTITUTUL NAIONAL DE ENDOCRINOLOGIE

OSTEOPOROZA: SUBDIAGNOSTICATA SI SUBTRATATA LA NIVEL MONDIAL

200 milioan ! " m i o#$ o%o&o$i' la ni( l mon!ial) !oa& *0+ !in$& 'a,-&i #-n$ !ia.no#$i'a$ mai %-$in ! 2*+ !in$& %a'i n$ #-n$ $&a$a$

1. Cooper C. Epidemiology of osteoporosis. Osteoporos Int 1999;9(suppl 2):S2-8

OSTEOPOROZA IN ROMANIA
*+ ))/*+
2881 pacie te recrutate de !edicii de "amilie 1#$% pacie te e&aluate de !edicii Specialisti

)0/1+ 2.000.000 " m i

osteoporoza cu fractura osteoporoza fara fractura osteopenie alt dg

peste %% a i i 'oma ia(

*Recensamantul populatiei si a locuintelor 2002,

Institutul National De Statistica

DEFINITIA OSTEOPOROZEI
)steoporo*a se defi e+te ca o ,oal- sc.eletic- caracteri*at- pri re*iste /- osoas- sca*ut-( ceea ce co fer- u risc crescut de fractur-. 'e*iste /a osoas- reflect- atat de sitatea cat +i calitatea osului.
012 Co se sus Co fere ce 2331

)s ormal

)steoporo*-

012 Co se sus 4e&elopme t 5a el o )steoporosis. 67!7 28% (2331): 88%-9%

DENSITOMETRIA OSOAS3 D4A

OMS: CRITERII DE DIAGNOSTIC IN OSTEOPOROZ35 DENSITOMETRIE DE4A

NORMAL:

scorul T < 1 DS scorul T 1DS 2.5 DS

OSTEOPENIE:

OSTEOPOROZ: scorul T < -2.5 DS OSTEOPOROZ SEVER (DOVEDIT : Os!"o#oro$% & c"l #u'() o *r+c!ur%

INCIDENA FRACTURILOR VERTEBRALE/ 6NC7EIETURA M8INII 9I 9OLD

$0

4r.......

F m i % #$ *0 ani
Vertebrale

nciden!a"an la #000 femei

%0

&0 old #0 ncheietura minii

50

60 70 80Vrsta (ani)

9as ic. '4: 5rimer o t.e !eta,olic :o e 4iseases a d 4isorders of !i eral !eta,olism. #t. editio ( 1999( p 2%8

E,+lu+r"+ s"-(c+)!(!+!(,% + *r+c!ur(lor ,"r!".r+l" r+/(o0r+*(c"

G&a!-l 0 No&mal
0ormal

) U:o&
7 terior !iddle !ild "racture 5osterior

2 Mo! &a$
7 terior !iddle !oderate "racture 5osterior

2S ( &
7 terior !iddle Se&ere "racture 5osterior

;e a t et al. J Bone Mineral Res 199<: 8; 11<8-#8

FRACTURILE VERTEBRALE5 PROBLEME DE DIAGNOSTIC

1#

1+

1#

1+

'enant et al( )*+, #--%.8/##%70$8(

FRACTURI VERTEBRALE 5 EPIDEMIOLOGIE 5

N-mai o $& im !in "&a'$-&il ( &$ ;&al o;# &(a$ % &a!io.&a"ii a<-n. la 'lini'ian #i mai %-=in ! )0+ n ' #i$> in$ &na& ?n #%i$al C@ia& !a'> Ai#$> o "&a'$-&> ( &$ ;&al> % &a!io.&a"i / &a& o&i #$ m n=iona$> ! '>$& &a!iolo. ?n "oaia ! o;# &(a=i #i m-l$ mai &a& #$ in!i'a$ -n $&a$am n$

R(s2 *or )"3 ,"r!".r+l *r+c!ur" *ollo3()0 *(rs! ,"r!".r+l *r+c!ur"

1 cide ce of e= &erte,ral fractures (>)
1%
RRB*.)

RRBC.2

13
RRB2.0

0um,er of &erte,ral fractures at start of study

282% post-me opausal =ome ( ra domi*ed place,o-co trolled

?i dsay et al. 67!7 2331; 28%:<23-2<

Evolutia masei osoase in raport cu varsta

#cumulare *onsoli0are 3ier0ere

Mas a osoa sa

Menopauza
1ar2ati

-30%

4emei 0 )0 $0 20 30 %0 &0

Risc de fractura
'0 (0

*ompston +E, Clinical Endocrinology, $--0.33/'&3-')2,

arsta !ani"

M"c4+)(s-s o* .o)" loss () 3o-") +)/ -")

P+!o0")(+ os!"o#oro$"( /" ,+rs!+

Pr",+l")c" o* ,(!+-() D ()+/"5u+c6 3(!4 /(**"r")! cu!-#o()! ,+lu"s ()07-l

E0.00+ 10.00+ C0.00+ 00.00+ P& (al n' *0.00+ D0.00+ 20.00+ 20.00+ )0.00+ 0.00+ F)0 F)* F20 F2* F20 F2* 22.22+ D2.22+ 00.EC+ C2.21+ 12.DE+ 11.E2+

'-$o"" %oin$# "o& 2*O 7D Gn.HmLI

G&i.o&i D. $ al./ 2001

M+)+0"-")!ul co"r")! +l os!"o#oro$"(

1 23aluarea pacientelor cu riscul cel mai crescut 1 24cluderea cauzelor secundare 1 5electia tratamentului adec3at

PRAGURILE DIAGNOSTICE NU SUNT EC7IVALENTE CU PRAGURILE INTERVENIEI TERAPEUTICE

CINE TREBUIE TRATATJ

Pa'i n=ii '- "&a'$-&i Pa'i n=ii '- o#$ o%o&o,> Pa'i n=ii '- %&o;a;ili$a$ '& #'-$> ! "&a'$-&> ?n -&m>$o&ii )0 ani 5 FRA4

IN8ORMATIILE NE9ESARE PT. 9AL9:L:L PRO;A;ILITATII DE 8RA9T:RA PE :RMATORII 1< ANI

1 1 1 1 1 tara densitatea minerala osoasa 3arsta se4ul factori de risc clinici
6 6 6 6 6 6 6 6 indice de masa corporala redus fracturi de fragilitate anterioare istoric familial de fractura de sold tratamente cortizonice fumat e4cesi3 consum e4cesi3 de alcool poliartrita reumatoida osteoporoze secundare

758,9+2789: ;2 <=:<9: =: >,=?

8RA=> IN PRA9TI9A 9LINI9A

1 R(scul /" *r+c!ur+ /"!"r-()+! cu 8RA= #o+!" *( u!(l($+! /" cl()(c(+) +s!*"l/ 1 ;aca riscul de fractura este -(c@ se fac recomandari de stil de 3iata (dieta@ e4ercitii fizice) dar tratamentul nu este necesar( 1 ;aca riscul este -+r" atunci clinicianul 3a recomanda un tratament( 1 ;aca riscul este ()!"r-"/(+r@ se recomanda masurarea ;+A( 5e recalculeaza apoi riscul >,=? si se decide daca medicatia este necesara( 1 >emeilor care au a3ut deBa o fractura dupa menopauza li se poate recomanda tratament fara a fi necesara calcularea riscului(

ALEGEREA AGENTULUI TERAPEUTIC 6N OSTEOPOROZ3

). C&i$ &ii ! "i'a'i$a$

K ma.ni$-!in a " '$-l-i an$i"&a'$-&> K #% 'i"i'i$a$ a " '$-l-i an$i"&a'$-&> K &a%i!i$a$ a " '$-l-i an$i"&a'$-&> 2. Si.-&an=>H$ol &a;ili$a$ 2. E" '$ A$&a#'@ l $i' D. Co#$5 "i'i n$a

Evolutia masei osoase su2 tratament antiosteoporotic

Ranelat 0e Strontiu Derivati 0e 358
6S5E646RM#56#RE
Menopauza

Mas a osoa sa

#N5IRES6R15I E 1i7os7onati"

$0

20

30

%0

&0

'0

(0

)0

*ompston +E, Clinical Endocrinology, $--0.33/'&3-')2,

arsta !ani"

R"/uc"r"+ -+s"( oso+s" l+ -")o#+u$+

M+s+ oso+s+ M+?(-u( P"+2 I-.+!r+)(r" M")o#+u$+

I-.+!r+)(r"

<

25

5<

55

@<

A5

V+rs!+ (+)(

;(l+)!ul osos Os !r+."cul+r

Nor-+l

N"0+!(,

N"0+!(,

---

Nor-+l

Su.!("r"

Su.!("r" & #"r*or+r"

9(clul r"-o/"l+r(( oso+s"

B:IES9EN9E Pr"-os!"ocl+s!"

Os!"o.l+s!" Os!"ocl+s!"

RESOR;TION

8ORMATION Pr"-os!"o.l+s!"

INVERSION

A%li'a$iil 'lini' al ! n#i$om $&i i o#oa# DE4A

Dia.no#$i'-l o#$ o%o&o, i E(al-a& a &i#'-l-i ! "&a'$-&a Moni$o&i,a& a $&a$am n$-l-i an$i& #o&;$i(

S'o&-l T
#'o&-&il T #i Z #-n$ #'o&-&i #$an!a&! ' 'on( &$ #' & ,-l$a$ l DMO al !i" &i$ lo& #'ann & la o #'ala 'om-na Da'a a& Ai#$a -n #in.-& $i% ! ! n#i$om $&- a& "i %& " &a$ '&i$ &i-l DMO in (aloa& a;#ol-$a S'o& T B n-ma&-l ! ! (ia$ii #$an!a&! % #$ #a#-; m !ia DMO a %o%-la$i i $in & ! & " &in$a

S'o&-l Z

S'o&-l Z B n-ma&-l ! ! (ia$ii #$an!a&! % #$ #a- #-; (aloa& a ! & " &in$a m !i a % &#oan lo& ! a' la#i # A #i a' a#i (a&#$a a&a$a !a'a (aloa& a DMO #$ ' a a#$ %$a$a % n$&- -n %a'i n$ n- Ai#$a -n '-$5%oin$ #% 'i"i' % n$&- 'a-, l # '-n!a&

U$ili,a& a #'o&-&ilo&

S'o&-l T #$ "olo#i$ % n$&- !ia.no#$i' LDMO #'a! '- (a&#$aM S'o&-l Z n- # -$ili, a,a % n$&- !ia.no#$i' la a!-l$i/ "olo#i& a #a a& #-. &a 'a %& (al n$a o#$ o%o&o, i n- '& #$ '- (a&#$a

In!i'a$ii % n$&- ! $ &mina& a DMO ISCD

" m i % #$ 0* ! ani " m i in %o#$m no%a-,a/ #-; 0* ! ani !a& '- "a'$o&i ! &i#' ;a&;a$i % #$ C0 ! ani a!-l$i '- "&a'$-&i ! "&a.ili$a$ a!-l$i '- ;oli #a- 'on!i$ii 'a& # a#o'ia,a '- ma#a o#oa#a #'a,-$a #a- %i &! & o#oa#a %a'i n$i la 'a& # 'on#i! &a o $ &a%i "a&ma'olo.i'a %a'i n$i a"la$i #-; $&a$am n$ Lmoni$o&i,a& " '$M %a'i n$i "a&a $&a$am n$ la 'a& (i! n$i & a %i &! &ii o#oa# a& 'on!-' la ini$i & a $ &a%i i

In!i'a$ii % n$&- ! $ &mina& a DMO NOF LNa$ional O#$ o%o&o#i# Fo-n!a$ionM

" m i % #$ 0* ! ani in!i" & n$ ! %& , n$a "a'$o&ilo& ! &i#' " m i in %o#$m no%a-,a mai $in & ! 0* ! ani/ '- -n-l #a- mai m-l$i "a'$o&i ! &i#' L A' %$an! &a#a al;a/ # A-l " minin #i %o#$m no%a-,aM " m i in %o#$m no%a-,a '- "&a'$-&i L% n$&'on"i&ma& !ia.no#$i'a #i a%& 'i & a # ( &i$a$ii ;oliiM

Ghidul european de diagnostic si tratament in osteoporoza

CD 0 riscuri absolute

<onceptul de 52,+

S electi& E stroge R eceptor Modulator

0u este u estroge sau u .ormo Se leag- de receptorii de estroge 7re efecte de tip estroge ic @ u ele /esuturi :loc.ea*- efectele estroge ilor @ u ele /esuturi

*isphosphonates/ ;ifferences in ,& 5ide <hain 5tructure

Zoledronic Acid Risedronate

O N O C P

OH
N

O O C P

OH

OH P OH HO OH
Alendronate

OH P OH OH OH
Ibandronate

H2N

O O C P

OH

CH

OH P OH OH OH

O C P

OH

OH P OH OH OH

+ecanism de actiune 0 *E

'ussel( )steoporos 1 t( 2338

Mo0i7icari 9istolo:ice 0upa tratament cu #len0ronat sau 358 in osteoporo;a

#len0ronat $0m:<;i 5eriparati0 20m:<;i

Marcare cu Tetraciclina

es from ME Arlot, Laboratoire dHistodynamique

sseuse L

=nabolice/ E8D@ teriparatide

1 1 1 1 1 1 creste turno3erul osos si masa osoasa creste apozitia periostala creste grosimea trabeculara si corticala si diametrul e4terior cresterea 3olumului trabecular@ a conecti3itatii ameliorare microarhitecturala si a proprietatilor biomecanice ale osului formarea de os tanar@ mai putin mineralizat

;elmas@ &006

Images courtesy JA Kanis